Inventor profile of:

David Klatzmann

City:

Paris

Country:

France

Published Applications:

31

Last publication date:

2024-11-14

Top Assignees for applications by David Klatzmann

The entities that hold a legal rights for patent applications filed by inventor Klatzmann David:

Recent patent applications by Klatzmann David

David Klatzmann from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-14
US20240376172A1
Chemistry; metallurgy

INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLAMED TISSUES

#2 | 2024-11-07
US20240366753A1
Human necessities

VIRAL-LIKE PARTICLES FOR THE TREATMENT OR PREVENTION OF AN INFECTION BY A CORONAVIRIDAE VIRUS

#3 | 2023-05-18
US20230149512A1
Human necessities

LOW DOSE IL-2 FOR TREATING AUTOIMMUNE-RELATED OR INFLAMMATORY DISORDERS

#4 | 2023-02-02
US20230036793A1
Chemistry; metallurgy

INTERLEUKIN 2 CHIMERIC CONSTRUCTS

#5 | 2021-09-30
US20210299195A1
Human necessities

VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES

#6 | 2021-08-05
US20210236599A1
Human necessities

COMBINATION OF INTERLEUKIN-2 WITH AN INTERLEUKIN 1 INHIBITOR, CONJUGATES AND THERAPEUTIC USES THEREOF

#7 | 2021-04-29
US20210121532A1
Human necessities

Use of interleukin 2 for treating Sjögren's syndrome

#8 | 2021-02-11
US20210038691A1
Human necessities

Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders

#9 | 2020-11-05
US20200347363A1
Chemistry; metallurgy

Virus-like particles which can be used in the treatment of autoimmune diseases

#10 | 2019-11-21
US20190351023A1
Human necessities

Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders

#11 | 2019-05-23
US20190151364A1
Human necessities

Genetically modified T lymphocytes

#12 | 2019-02-28
US20190060407A1
Human necessities

USE OF INTERLEUKIN 2 FOR TREATING SPONDYLOARTHRITIS

#13 | 2018-08-16
US20180228913A1
Human necessities

PROTOZOAN VARIANT-SPECIFIC SURFACE PROTEINS (VSP) AS CARRIERS FOR ORAL DRUG DELIVERY

#14 | 2017-12-07
US20170349634A1
Chemistry; metallurgy

Compositions and methods for treatment of cytomegalovirus

#15 | 2017-10-26
US20170304402A1
Human necessities

Use of low dose IL-2 for treating autoimmune related or inflammatory disorders

#16 | 2017-01-26
US20170020962A1
Human necessities

Interleukin-2 for treating food allergy

#17 | 2015-06-11
US20150157735A1
Human necessities

Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery

#18 | 2014-09-11
US20140255445A1
Chemistry; metallurgy

Synthetic viruses and uses thereof

#19 | 2014-08-21
US20140236621A1
Physics

METHOD FOR DETERMINING A PREDICTIVE FUNCTION FOR DISCRIMINATING PATIENTS ACCORDING TO THEIR DISEASE ACTIVITY STATUS

#20 | 2014-03-18
US10415242
-

Synthetic viruses and uses thereof

#21 | 2014-01-09
US20140011739A1
Human necessities

Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery

#22 | 2014-01-02
US20140004080A1
Human necessities

Method for stimulating T lymphocytes with IL-2

#23 | 2013-04-18
US20130095133A1
Human necessities

Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof

#24 | 2010-09-16
US20100233144A1
Chemistry; metallurgy

METHOD FOR OPTIMIZING BLOOD CELL TRANSPLANTS

#25 | 2010-08-26
US20100215629A1
Chemistry; metallurgy

TREATMENT OF TUMORS USING T LYMPHOCYTE PREPARATIONS

#26 | 2008-08-28
US20080206210A1
Human necessities

Treating immunodeficiencies by intrathymic injection of nucleotide sequences

#27 | 2007-06-07
US20070128670A1
Chemistry; metallurgy

Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof

#28 | 2007-01-18
US20070015258A1
Chemistry; metallurgy

α-β C4BP-type recombinant heteromultimeric proteins

#29 | 2006-07-11
US8983474
-

α-β C4BP-type recombinant heteromultimeric proteins

#30 | 2005-03-29
US9978931
-

Highly productive packaging lines

#31 | 2005-03-03
US20050048471A1
Chemistry; metallurgy

Albumin derivatives with therapeutic functions

InventorID:

595598 ⎘